U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H26O3
Molecular Weight 290.3972
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXABOLONE

SMILES

[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C(O)=C4CC[C@@]23[H]

InChI

InChIKey=GXHBCWCMYVTJOW-YGRHGMIBSA-N
InChI=1S/C18H26O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h10-12,14,16,20-21H,2-9H2,1H3/t10-,11-,12-,14+,16+,18+/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://pilarmartinescudero.es/EneroFebreroMarzo2014/capillary_investigation_oxabolone_man.pdf and http://www.basskilleronline.com/profile-steranabol.shtml

Oxabolone is a synthetic anabolic steroid. It can be formulated as the cipionate ester prodrug oxabolone cipionate. Oxabolone cypionate is a structural derivative of nandrolone. It differs via the additional 4-hydroxyl group that is attached, therefore making oxabolone cypionate 4-hydroxynandrolone. Oxabolone is on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most major sports. Oxabolone cypionate is a relatively rare drug that was once produced in Europe for human use. Was used for the treatment of osteoporosis. It is no longer produced by pharmaceutical companies; Upjohn and Pharmacia were the primary producers of it previously.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Primary
Steranabol

Approved Use

Indications: anabolic, osteoporosis, diabetic retinopathy
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

The recommended dosage is 100-300 mg/week for about 6-12 weeks
Route of Administration: Intramuscular
In Vitro Use Guide
Unknown
Name Type Language
OXABOLONE
MI  
Common Name English
4-HYDROXY-19-NORTESTOSTERONE
Common Name English
4-HYDROXY NANDROLONE
Common Name English
ESTR-4-EN-3-ONE, 4,17-DIHYDROXY-, (17.BETA.)-
Systematic Name English
OXABOLONE [MI]
Common Name English
Classification Tree Code System Code
DEA NO. 4000
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
WHO-ATC A14AB03
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
225-212-2
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
MERCK INDEX
m379
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY Merck Index
PUBCHEM
20055236
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
EPA CompTox
DTXSID50878357
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
DRUG BANK
DB01500
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
WIKIPEDIA
OXABOLONE
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
FDA UNII
51RPF719WE
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
DRUG CENTRAL
3802
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY
CAS
4721-69-1
Created by admin on Fri Dec 15 20:11:19 GMT 2023 , Edited by admin on Fri Dec 15 20:11:19 GMT 2023
PRIMARY